173 related articles for article (PubMed ID: 32986360)
1. Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.
Hosseini-Valiki F; Taghiloo S; Tavakolian G; Amjadi O; Tehrani M; Hedayatizadeh-Omran A; Alizadeh-Navaei R; Zaboli E; Shekarriz R; Asgarian-Omran H
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2615-2621. PubMed ID: 32986360
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
3. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
[TBL] [Abstract][Full Text] [Related]
4. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.
Rangachari M; Zhu C; Sakuishi K; Xiao S; Karman J; Chen A; Angin M; Wakeham A; Greenfield EA; Sobel RA; Okada H; McKinnon PJ; Mak TW; Addo MM; Anderson AC; Kuchroo VK
Nat Med; 2012 Sep; 18(9):1394-400. PubMed ID: 22863785
[TBL] [Abstract][Full Text] [Related]
5. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
6. Frequency and functional characterization of exhausted CD8
Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
[TBL] [Abstract][Full Text] [Related]
7. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
[TBL] [Abstract][Full Text] [Related]
10. The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.
Grzywnowicz M; Karabon L; Karczmarczyk A; Zajac M; Skorka K; Zaleska J; Wlasiuk P; Chocholska S; Tomczak W; Bojarska-Junak A; Dmoszynska A; Frydecka I; Giannopoulos K
Leuk Lymphoma; 2015; 56(10):2908-13. PubMed ID: 25682964
[TBL] [Abstract][Full Text] [Related]
11. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
[TBL] [Abstract][Full Text] [Related]
14. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
[TBL] [Abstract][Full Text] [Related]
15. [TIM-3/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia].
Xierenguli A; Zeng X; Pang N; Zhagn R; Ma J; Zhao Y; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1021-1025. PubMed ID: 33210597
[TBL] [Abstract][Full Text] [Related]
16. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia.
Taghiloo S; Allahmoradi E; Ebadi R; Tehrani M; Hosseini-Khah Z; Janbabaei G; Shekarriz R; Asgarian-Omran H
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2269-2274. PubMed ID: 28843266
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of HLA-B-associated transcript 3 impairs the tumoricidal effect of natural killer cells through promoting the T cell immunoglobulin and mucin domain-containing-3 signaling in a mouse head and neck squamous cell carcinoma model.
Yang J; Xiang J; Zhu M; Zhao Y; Zhou L; Hu B; Wang C
Immunobiology; 2022 Jan; 227(1):152127. PubMed ID: 34968777
[TBL] [Abstract][Full Text] [Related]
19. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.
Saresella M; Piancone F; Marventano I; La Rosa F; Tortorella P; Caputo D; Rovaris M; Clerici M
FASEB J; 2014 Nov; 28(11):5000-9. PubMed ID: 25091272
[TBL] [Abstract][Full Text] [Related]
20. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
